Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients ...
Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer
Est. EPS $1.36 · Revenue $1.15B · 11 analysts
Est. EPS $5.35 · Revenue $4.62B · 11 analysts
Est. EPS $1.33 · Revenue $1.16B · 4 analysts
Est. EPS $1.49 · Revenue $1.21B · 4 analysts
EPS $0.82 · Revenue $1.04B
| Metric | Latest | YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength. | QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes. |
|---|---|---|---|
| RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three). | $4.3B | -0.8% | +6.2% |
| Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day. | $850.0M | +169.5% | +54.5% |
| Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials. | +66.7% | +1.9% | +0.5% |
| Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on). | +19.9% | +204.5% | +10.3% |
| Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales. | +19.6% | +170.0% | +45.4% |
| Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock. | $931.0M | +31.3% | -35.9% |
| FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine. | +21.5% | +32.3% | -39.6% |
| Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe. | 93.8% | -15.1% | -6.3% |
| Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking. | 2.08x | +16.9% | +2.7% |
| Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground. | $6.6B | +5.4% | +1.4% |
| Metric | Annual (A vs E) | Annual Surprise | Quarter (A vs E) | Quarter Surprise |
|---|---|---|---|---|
| EPS Surprise | 5.45 vs 4.73 | +15.2% | 1.35 vs 1.36 | -0.6% |
| Revenue Surprise | $4.3B vs $4.3B | +0.8% | $1.2B vs $1.2B | +0.5% |
| Date | Executive | Title | Security | Side | Shares | Price |
|---|---|---|---|---|---|---|
| Aug 27, 2026 | Meister Keith A. | director | Common Stock | D | 4,873 | $226.74 |
| Aug 27, 2026 | Meister Keith A. | director | Common Stock | D | 54,309 | $227.67 |
| Aug 27, 2026 | Meister Keith A. | director | Common Stock | D | 24,363 | $228.64 |
| Aug 27, 2026 | Meister Keith A. | director | Common Stock | D | 16,990 | $229.72 |
| Aug 27, 2026 | Meister Keith A. | director | Common Stock | D | 28,439 | $230.54 |
Operator: Good day, ladies and gentlemen. Welcome to the second quarter 2026 Illumina earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, we will conduct a question and answer session. Please be advised that today's conference is being recorded. I would now like to hand the call over to head of investor relations, Conor McNamara. Conor McNamara: Hello, everyone. Welcome to Illumina's second quarter 2026 earnings call. Today, we will review our financial results, released after market close, and provide prepared remarks before opening the line for questions and answers. Our earnings release is available in the investor relations section of illumina.com. Joining me today are Jacob Thaysen, Chief Executive Officer, and Ankur Dhingra, Chief Financial Officer. Jacob will begin with an update on Illumina's business, followed by Ankur's review of the financials. We will be discussing certain non-GAAP financial measures, and a reconciliation to GAAP can be found in today's release and in the supplementary data on our website. Unless otherwise stated, all growth rates are presented on a year-over-year reported basis. Organic growth adjusts for the impact of currency and acquisitions, and rest of world organic growth also excludes Greater China due to our inclusion on China's unreliable entity list. This call is being recorded. The replay will be available on our website. It is our intent that all forward-looking statements made during today's call will be protected under the Private Securities Litigation Reform Act of 1995. To better understand the risks and uncertainties that could cause actual results to differ, we refer you to the documents that Illumina files with the SEC, including our most recent Forms 10-Q and 10-K. With that, I will now turn the call over to Jacob. Jacob Thaysen: Thank you, Conor. Good afternoon, everyone. We had a great first half of 2026, including another strong quarter in Q2. I couldn't be prouder of what the Illumina team delivered. Revenue grew at the fastest rate since I joined the company, driven by increasing demand for Illumina's technology as customers expand clinical applications. Our deep relationships with leading U.S. clinical customers and large installed base reinforce the durability of our position in these markets. Margins also came in above our guidance despite higher than expected costs. I want to thank our teams for their focus and commitment to our customers and shareholders. Our first half results puts us in a strong position as we look ahead. We are raising our 2026 guidance for revenue growth and profitability while remaining committed to executing against our long-range targets. Today, I'm going to focus on three areas: our performance in the quarter and the trends we are seeing across our end markets, how we are expanding the value of our platform through new workflows and multi-omics capabilities, and the progress we are making …
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
Jacob Thaysen | Chief Executive Officer & Director | USD 2,255,773 | Male | 1975 | Active |
Ankur Dhingra | Chief Financial Officer | USD 985,992 | Male | 1976 | Active |
Steven Barnard | Chief Technology Officer | USD 917,976 | — | 1961 | Active |
Kevin Carl Pegels | Chief of Global Operations | USD 882,992 | Male | 1968 | Active |
Mark Field | Chief Information Officer | USD 693,519 | Male | 1971 | Active |
Patricia Leckman | Senior Vice President & Chief People Officer | — | Female | 1964 | Active |
Scott Davies | Chief Legal Officer & Secretary | — | Male | 1970 | Active |
Scott Ericksen | Vice President & Chief Accounting Officer | — | Male | 1973 | Active |
Julie Ann Coletti | Chief Legal Officer | — | Female | 1968 | Active |
Conor Noel McNamara | Vice President of Investor Relations | — | Male | — | Active |
Stephanie Campos | President | — | — | — | Active |
Jakob Wedel | Chief Strategy & Corporate Development Officer | — | Male | 1972 | Active |
Illumina (ILMN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
The headline numbers for Illumina (ILMN) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Illumina, Inc. (ILMN) Q2 2026 Earnings Call Transcript
Illumina (ILMN) came out with quarterly earnings of $1.31 per share, beating the Zacks Consensus Estimate of $1.23 per share. This compares to earnings of $1.19 per share a year ago.
SAN DIEGO, July 30, 2026 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the second quarter of fiscal year 2026. Second quarter 2026 results Revenue of $1.16 billion for Q2 2026, up 9.5% from Q2 2025 and up 8.1% excluding the impacts of currency, acquisitions, and China ("ROW1 organic revenue growth") GAAP operating margin of 21.1% and non-GAAP operating margin of 22.5% GAAP diluted EPS of $1.35 and non-GAAP diluted EPS of $1.31 "Illumina delivered strong results during the second quarter.
